Presentation Complex Coronary Cases 2023 My Best Cardiogenic Shock Case: A Save Presenter: Kate Kearney June 15, 2023
Presentation Complex Coronary Cases 2023 App Technology in Shock Presenter: Annapoorna S. Kini June 15, 2023
Presentation Complex Coronary Cases 2023 National Cardiogenic Shock Initiative Presenter: William O’Neill June 15, 2023
Presentation Complex Coronary Cases 2023 ACS and Antiplatelet Therapies2023 Presenter: Joseph M. Sweeny June 14, 2023
News Daily News CABG and PCI Comparable in ACS Patients With Left Main CAD Michael O'Riordan June 06, 2023
News Conference News EAS 2023 With New LDL Goalposts in FH, Combo Therapy Must Start Early Michael O'Riordan May 29, 2023
News Conference News EAS 2023 Multipronged Outreach to Families Can Boost FH Cascade Screening: IMPACT-FH Michael O'Riordan May 26, 2023
News Conference News EuroPCR 2023 QFR More Consistent Than FFR in Nonculprit Lesions After STEMI Caitlin E. Cox May 24, 2023
News Conference News EuroPCR 2023 Meta-analysis Finds No Excess Mortality Risk With Coronary Revascularization Michael O'Riordan May 19, 2023
News Conference News SCAI 2023 DIPRA Quells Fears Over Distal Radial Cath and Hand Function at 1 Year L.A. McKeown May 19, 2023
News Daily News Enough PCI ‘Versus’ CABG—Time to Focus on Understudied Groups Michael O'Riordan May 09, 2023
News Daily News To Boost Access and Outcomes With New PCI Centers, Location Matters L.A. McKeown May 08, 2023
News Daily News Oxidized Phospholipids and Lp(a) Strongly Associated With MACE: CASABLANCA Michael O'Riordan May 03, 2023
News Daily News Sugary Drinks Up CVD and All-Cause Mortality Risks in Type 2 Diabetes Michael O'Riordan May 01, 2023
News Daily News A Bivalirudin Rebuttal: ‘Some Issues’ to Discuss With BRIGHT-4 Shelley Wood April 14, 2023
News Daily News Around the World, Finances Impact Acute MI Outcomes in Older Adults Caitlin E. Cox April 04, 2023
News Daily News Physiologic Testing May ID Patients Who’ll Still Have Angina After PCI Michael O'Riordan March 31, 2023
News Conference News ACC 2023 STREAM-2: Half-Dose Tenecteplase Safe, Effective in Older STEMI Patients L.A. McKeown March 10, 2023